XML 19 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
Total
Preferred Series A Stock
Preferred Series B Stock
Preferred Series D Stock
Common Stock
Common Shares to be issued
Treasury Stock
Additional Paid in Capital
Non-Controlling Interest
Accumulated Deficit
Beginning balance at Dec. 31, 2015 $ 116,288 $ 71   $ 26,298 $ (224,250) $ 28,523,689 $ (28,209,520)
Beginning balance, shares at Dec. 31, 2015   51 71,210   1,051,933          
Common stock sold in private placement 2,300,000   $ 2,567   2,297,433  
Common stock sold in private placement, shares     102,679          
Common stock issued to placement agent (0)   $ 104   (104)  
Common stock issued to placement agent, shares     4,154          
Fees paid to placement agent (221,172)     (221,172)  
Common stock issued for services 4,452,484   $ 3,910   4,448,574  
Common stock issued for services, shares     156,384          
Vesting of common shares 2,764,501     2,764,501  
Common stock exchanged for preferred stock mezzanine (2,053,571)   $ (2,567)   (2,051,004)  
Common stock exchanged for preferred stock mezzanine, shares     (102,679)          
Preferred stock converted to common stock $ (71)   $ 12,500   (12,429)  
Preferred stock converted to common stock, shares   (71,210)   500,000          
Vesting of common stock options 3,250     3,250  
Net loss (17,691,060)       (17,691,060)
Ending balance at Dec. 31, 2016 (10,329,280)   $ 42,812 (224,250) 35,752,738   (45,900,580)
Ending balance, shares at Dec. 31, 2016   51   1,712,471          
MSTI common shares       $ 10,097 16,979   (27,076)    
MSTI common shares, shares         403,865          
Common Stock Offering - January, net of costs of $1,626,198 10,764,931       $ 75,000     10,689,931    
Common Stock Offering - January, net of costs of $1,626,198, shares         3,000,000          
Common shares issued to Officer       $ 5,316     (5,316)    
Common shares issued to Officer, shares         212,654          
Stock options issued to Officers and vesting of stock options 3,409,397             3,409,397    
Shares issed to Goldman Sachs Speciality Lending Group 1,242,912       $ 10,533     1,232,379    
Shares issed to Goldman Sachs Speciality Lending Group, shares         421,326          
Series C Preferred Shares converted to Common Shares 2,644,937       $ 27,037     2,617,900    
Series C Preferred Shares converted to Common Shares, shares         1,081,472          
Common Shares issued in connection with CFS Group acquisiiton 1,251,000       $ 12,500     1,238,500    
Common Shares issued in connection with CFS Group acquisiiton, shares         500,000          
Common shares issued to Directors and Consultants 842,950       $ 11,384     831,566    
Common shares issued to Directors and Consultants, shares         455,363          
Common Stock Offering - June, net of costs of $538,554 3,486,446       $ 57,500     3,428,946    
Common Stock Offering - June, net of costs of $538,554, shares         2,300,000          
Series C dividend shares       $ 728     (728)    
Series C dividend shares, shares         29,126          
Sale of Series D Preferred Shares, net of costs of $136,800 1,271,030     $ 531,691 $ 10,575     728,764    
Sale of Series D Preferred Shares, net of costs of $136,800, shares       141,000 423,000          
Series D dividend shares 2,170       $ 2,170          
Series D dividend shares, shares         86,769          
Common Shares issued in connection with DxT acquisiiton 318,500       $ 8,750     309,750    
Common Shares issued in connection with DxT acquisiiton, shares         350,000          
Sale of Series E Preferred Shares, net of costs of $309,000 734,356             734,356    
Series E dividend shares issued in 2018 703,168         703,168        
Common Stock Offering - November, net of costs of $240,250 1,684,719       $ 46,691     1,638,028    
Common Stock Offering - November, net of costs of $240,250, shares         1,868,933          
Common Shares and Warrants issued in connection with Verifi Labs acquisition 1,896,645       $ 25,000     1,871,645    
Common Shares and Warrants issued in connection with Verifi Labs acquisition, shares         1,000,000          
Common Shares issued in connection with ALB acquisition 1,032,000       $ 20,000     1,012,000    
Common Shares issued in connection with ALB acquisition, shares         800,000          
Common shares to Employee issued in 2018 65,000             65,000    
Warrant exercise 4,750       $ 63     4,687    
Warrant exercise, shares         2,500          
Non-controlling interest related to acquisitions 1,374,688               1,374,688  
Dividend to Non-controlling interest (38,804)               (38,804)  
Net loss (39,037,489)               123,523 (39,161,012)
Ending balance at Dec. 31, 2017 $ (16,675,975) $ 531,691 $ 366,156 $ 720,147 $ (224,250) $ 65,532,467 $ 1,459,407 $ (85,061,593)
Ending balance, shares at Dec. 31, 2017   51 141,000 14,647,479